Search

Your search keyword '"Hargroves, David"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Hargroves, David" Remove constraint Author: "Hargroves, David"
117 results on '"Hargroves, David"'

Search Results

1. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial

2. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

3. World Federation for Interventional Stroke Treatment (WIST) Multispecialty Training Guidelines for Endovascular Stroke Intervention

5. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

6. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

7. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial

8. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

11. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

12. Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage

14. World Federation for Interventional Stroke Treatment (WIST) multispecialty training guidelines for endovascular stroke intervention

15. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis

17. Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy

18. Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)

20. Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study

21. Neuroimaging Findings in Symptomatic Hypertensive Encephalopathy

22. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.

25. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

26. Research Data1 - Supplemental material for Establishment of an internationally agreed minimum data set for acute telestroke

27. JTT899262 Supplemental Material2 - Supplemental material for Establishment of an internationally agreed minimum data set for acute telestroke

28. Baseline factors associated with early and late death in intracerebral haemorrhage survivors

29. Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia

30. Establishment of an internationally agreed minimum data set for acute telestroke

31. Cognitive Impairment Before Atrial Fibrillation–Related Ischemic Events: Neuroimaging and Prognostic Associations

34. Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA

36. Establishment of an internationally agreed minimum data set for acute telestroke.

38. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

39. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

40. The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2

41. Patient Reported Outcome Measures (Promu2019S) : England Pilot To inform National Strategy and Assess Patient Needs Against Delivery of The Nhs Long Term Plan For Stroke

42. National initiative in England To Reduce Unwarranted Variation : Getting in Right First Time (Girft) U2013 Stroke Program

43. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

48. Anticoagulant selection in relation to the SAMe-TT2R2score in patients with atrial fibrillation: The GLORIA-AF registry

49. Computed Tomography Perfusion in Acute Stroke Assessment.

Catalog

Books, media, physical & digital resources